Targeting of daunorubicin by association with DNA or proteins: a review.
D000818:Animals; D000903:Antibiotics, Antineoplastic; D000906:Antibodies / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000188:drug therapy; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D004247:DNA / Q000008:administration & dosage* / Q000378:metabolism; D003630:Daunorubicin / Q000008:administration & dosage* / Q000031:analogs & derivatives / Q000378:metabolism; D006321:Heart / Q000187:drug effects; D006801:Humans; D008113:Liver Neoplasms; D009279:Naphthacenes / Q000378:metabolism; D011506:Proteins / Q000008:administration & dosage*; D012709:Serum Albumin / Q000008:administration & dosage
D000903:Antibiotics, Antineoplastic; D000906:Antibodies; D009279:Naphthacenes; D011506:Proteins; D012709:Serum Albumin; D004247:DNA; D003630:Daunorubicin